Cited by 16Pancreatic function and diabetesTissue Engineering and Regenerative MedicineDiabetes and associated disorders

Pancreatic islets seeded in a novel bioscaffold forms an organoid to rescue insulin production and reverse hyperglycemia in models of type 1 diabetes

Open access
Elizondo, Diana M., Brandy, Nailah Z. D., da Silva, Ricardo L. L., de Moura, Tatiana R., Ali, Jamel, Yang, Dazhi, Lipscomb, Michael W.·2020·Scientific Reports

Abstract

Therapeutic approaches to combat type 1 diabetes (T1D) include donor pancreas transplantation, exogenous insulin administration and immunosuppressive therapies. However, these clinical applications are limited due to insufficient tissue compatible donors, side effects of exogenous insulin administration and/or increased onset of opportunistic infections attributable to induced global immunosuppression. An alternative approach to alleviate disease states is to utilize insulin-producing pancreatic islets seeded in a bioscaffold for implantation into diabetic recipients. The present studies now report that a newly developed cationic polymer biomaterial serves as an efficient bioscaffold for delivery of donor syngeneic pancreatic islet cells to reverse hyperglycemia in murine streptozotocin induced- or non-obese diabetic mouse models of T1D. Intraperitoneal implantation of pancreatic islets seeded within the copolymer bioscaffold supports long-term cell viability, response to extracellular signaling cues and ability to produce soluble factors into the microenvironment. Elevated insulin levels were measured in recipient diabetic mice upon implantation of the islet-seeded biomaterial coupled with reduced blood glucose levels, collectively resulting in increased survival and stabilization of metabolic indices. Importantly, the implanted islet-seeded biomaterial assembled into a solid organoid substructure that reorganized the extracellular matrix compartment and recruited endothelial progenitors for neovascularization. This allowed survival of the graft long-term in vivo and access to the blood for monitoring glucose levels. These results highlight the novelty, simplicity and effectiveness of this biomaterial for tissue regeneration and in vivo restoration of organ functions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-020-60947-x

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Human pancreas organoids can be generated from ALDHhigh stem cells and have the potential to produce insulin, but in vivo evidence for engraftment is not yet available.

    “Human pancreas organoids can be generated from ALDHhigh stem cells and have the potential to produce insulin146 without in vivo evidence yet to confirm engraftment.”

    From Organoids (2022) · cites this paper as [146]

    The Discussion (page unavailable) reports insulin production by pancreatic islets seeded in a biomaterial, supporting the general point that the organoid-like construct can produce insulin. The Methods identify the islets as mouse-derived, not human ALDHhigh stem cells. The Abstract also reports long-term graft survival in vivo, though that finding does not establish engraftment of the human stem-cell organoids described in the claim. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Organoids of murine intestines, livers, and pancreas were successfully transplanted into mice, and the transplanted organoids could restore organ dysfunction.

    “Organoids of murine intestines31, livers35,125,126 and pancreas69,146 were successfully transplanted into mice, and the transplanted organoids could restore organ dysfunction.”

    From Organoids (2022) · cites this paper as [146]

    For the pancreatic portion of the sentence, the Introduction reports that donor mouse islets seeded in a bioscaffold were implanted into diabetic mice, and the Results report restored insulin levels and reduced hyperglycemia. The qualification is that the pancreas-like organoid assembled after implantation; the paper does not report transplanting a preformed organoid. The intestine and liver examples have separate citations and are not assessed here. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Elizondo, D. M., Brandy, N. Z. D., da Silva, R. L. L., de Moura, T. R., Ali, J., Yang, D., & Lipscomb, M. W.
Affiliations
  • Howard University (US)
  • Florida A&M University - Florida State University College of Engineering (US)
Corresponding author
Lipscomb, Michael W.
Venue
Scientific Reports
Published
2020-03-09
Volume
10
Issue
1
Pages
4362-4362
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3010313464
Cited by
16
References
41
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 4
FWCI
2.28
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Science Foundation (1428768)
  • U.S. Department of Defense (W911NF1410123)
  • National Institutes of Health
  • National Institute of General Medical Sciences (SC1GM127207)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
type 1 diabetes, pancreatic islets, islet transplantation, bioscaffolds, insulin production, hyperglycemia reversal, streptozotocin-induced diabetes, NOD mice, neovascularization, endothelial progenitor cells, extracellular matrix, graft survival, tissue regeneration
MeSH terms
Animals, Blood Glucose, Cell Survival, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 1, Graft Survival, Hyperglycemia, Insulin, Islets of Langerhans, Organoids, Islets of Langerhans Transplantation, Tissue Culture Techniques, Mice, Tissue Scaffolds

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review